Invention Grant
- Patent Title: Progesterone formulations
-
Application No.: US14125547Application Date: 2013-06-18
-
Publication No.: US10052386B2Publication Date: 2018-08-21
- Inventor: Brian A. Bernick , Julia M. Amadio , Peter H. R. Persicaner , Janice Louise Cacace , Thorsteinn Thorsteinsson , Frederick D. Sancilio
- Applicant: TherapeuticsMD, Inc.
- Applicant Address: US FL Boca Raton
- Assignee: TherapeuticsMD, Inc.
- Current Assignee: TherapeuticsMD, Inc.
- Current Assignee Address: US FL Boca Raton
- Agency: Sterne Kessler Goldstein & Fox
- Agent Matthew Bodenstein
- International Application: PCT/US2013/046442 WO 20130618
- International Announcement: WO2013/192248 WO 20131227
- Main IPC: A61K31/57
- IPC: A61K31/57 ; A61K31/56 ; A61K47/44 ; A61K47/10 ; A61K47/14 ; A61K31/573 ; A61K31/566 ; A61K9/00 ; A61K31/565 ; A61K9/48 ; A61K45/06 ; A61K9/107
Abstract:
Various pharmaceutical formulations are disclosed herein. For example, a pharmaceutical formulation is disclosed comprising ultra-micronized progesterone.
Public/Granted literature
- US20150148323A1 PROGESTERONE FORMULATIONS Public/Granted day:2015-05-28
Information query
